These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 9528753

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B, Lilischkis R, Sutherland RL.
    J Biol Chem; 1997 Dec 26; 272(52):33327-37. PubMed ID: 9407125
    [Abstract] [Full Text] [Related]

  • 23. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 24. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M.
    Exp Cell Res; 1999 Dec 15; 253(2):503-10. PubMed ID: 10585273
    [Abstract] [Full Text] [Related]

  • 25. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ, Swarbrick A, Sutherland RL, Musgrove EA.
    Oncogene; 1998 Jun 04; 16(22):2865-78. PubMed ID: 9671407
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK, Obaya AJ, Sedivy JM.
    Mol Cell Biol; 1999 Jul 04; 19(7):4672-83. PubMed ID: 10373516
    [Abstract] [Full Text] [Related]

  • 28. Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.
    Tedesco D, Baron L, Fischer-Fantuzzi L, Vesco C.
    J Virol; 1997 Mar 04; 71(3):2217-24. PubMed ID: 9032356
    [Abstract] [Full Text] [Related]

  • 29. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD, Weinberg RA.
    Mol Cell Biol; 1997 Jul 04; 17(7):4059-69. PubMed ID: 9199341
    [Abstract] [Full Text] [Related]

  • 30. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
    Tamir A, Petrocelli T, Stetler K, Chu W, Howard J, Croix BS, Slingerland J, Ben-David Y.
    Cell Growth Differ; 2000 May 04; 11(5):269-77. PubMed ID: 10845428
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW, Montalvo E, Massagué J.
    J Biol Chem; 1997 Oct 10; 272(41):25863-72. PubMed ID: 9325318
    [Abstract] [Full Text] [Related]

  • 33. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 34. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R, Finney GL, Carroll JS, Lee CS, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Dec 01; 62(23):6916-23. PubMed ID: 12460907
    [Abstract] [Full Text] [Related]

  • 35. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 15; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 37. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E.
    Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654
    [Abstract] [Full Text] [Related]

  • 38. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 39. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 40. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.
    Cell Growth Differ; 2001 Jun 01; 12(6):285-95. PubMed ID: 11432803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.